Share Print

Advice on Avastin


Aug. 4, 2010 – Recently, an FDA advisory committee voted 12-1 to remove an indication for breast cancer use from the drug Avastin. In this episode of Cancer Connection, Siteman Cancer Center medical oncologist Michael Naughton, MD, says for now doctors at Siteman will continue to administer Avastin to breast cancer patients. Naughton, who specializes in breast cancer treatment, says the drug is used to treat other cancers, particularly colon and lung cancer. He adds that Siteman doctors still believe Avastin is a good drug for breast cancer patients, but there are plenty of other options. However, he says most of the other options are chemotherapy drugs, whereas Avastin is a targeted therapy drug.

Related Content: